Outset Medical Inc. (OM)
Outset Medical Statistics
Share Statistics
Outset Medical has 17.7M shares outstanding. The number of shares has increased by 0.03% in one year.
| Shares Outstanding | 17.7M |
| Shares Change (YoY) | 0.03% |
| Shares Change (QoQ) | 0.87% |
| Owned by Institutions (%) | 41.69% |
| Shares Floating | 17.25M |
| Failed to Deliver (FTD) Shares | 12.78K |
| FTD / Avg. Volume | 13.73% |
Short Selling Information
The latest short interest is 6.46M, so 12.2% of the outstanding shares have been sold short.
| Short Interest | 6.46M |
| Short % of Shares Out | 12.2% |
| Short % of Float | 12.39% |
| Short Ratio (days to cover) | 4.5 |
Valuation Ratios
The PE ratio is -6.76 and the forward PE ratio is -0.95. Outset Medical's PEG ratio is 0.23.
| PE Ratio | -6.76 |
| Forward PE | -0.95 |
| PS Ratio | 7.61 |
| Forward PS | 1.1 |
| PB Ratio | 32.25 |
| P/FCF Ratio | -7.38 |
| PEG Ratio | 0.23 |
Enterprise Valuation
Outset Medical Inc. has an Enterprise Value (EV) of 335.95M.
| EV / Earnings | -2.63 |
| EV / Sales | 2.95 |
| EV / EBITDA | -3.43 |
| EV / EBIT | -2.96 |
| EV / FCF | -2.87 |
Financial Position
The company has a current ratio of 5.69, with a Debt / Equity ratio of 0.17.
| Current Ratio | 5.69 |
| Quick Ratio | 4.38 |
| Debt / Equity | 0.17 |
| Total Debt / Capitalization | 14.32 |
| Cash Flow / Debt | -25.94 |
| Interest Coverage | -4.75 |
Financial Efficiency
Return on equity (ROE) is -4.77% and return on capital (ROIC) is -363.59%.
| Return on Equity (ROE) | -4.77% |
| Return on Assets (ROA) | -0.46% |
| Return on Capital (ROIC) | -363.59% |
| Revenue Per Employee | $236,852.08 |
| Profits Per Employee | $-266,616.67 |
| Employee Count | 480 |
| Asset Turnover | 0.41 |
| Inventory Turnover | 1.27 |
Taxes
| Income Tax | 491K |
| Effective Tax Rate | 0 |
Stock Price Statistics
The stock price has increased by -62.43% in the last 52 weeks. The beta is 2.01, so Outset Medical's price volatility has been higher than the market average.
| Beta | 2.01 |
| 52-Week Price Change | -62.43% |
| 50-Day Moving Average | 11.32 |
| 200-Day Moving Average | 20.99 |
| Relative Strength Index (RSI) | 60.44 |
| Average Volume (20 Days) | 93.06K |
Income Statement
In the last 12 months, Outset Medical had revenue of 113.69M and earned -127.98M in profits. Earnings per share was -2.46.
| Revenue | 113.69M |
| Gross Profit | 38.56M |
| Operating Income | -113.38M |
| Net Income | -127.98M |
| EBITDA | -97.89M |
| EBIT | -113.38M |
| Earnings Per Share (EPS) | -2.46 |
Balance Sheet
The company has 124.01M in cash and 4.48M in debt, giving a net cash position of 119.53M.
| Cash & Cash Equivalents | 124.01M |
| Total Debt | 4.48M |
| Net Cash | 119.53M |
| Retained Earnings | -1.09B |
| Total Assets | 275.8M |
| Working Capital | 212.84M |
Cash Flow
In the last 12 months, operating cash flow was -116.3M and capital expenditures -912K, giving a free cash flow of -117.22M.
| Operating Cash Flow | -116.3M |
| Capital Expenditures | -912K |
| Free Cash Flow | -117.22M |
| FCF Per Share | -2.26 |
Margins
Gross margin is 33.92%, with operating and profit margins of -99.72% and -112.57%.
| Gross Margin | 33.92% |
| Operating Margin | -99.72% |
| Pretax Margin | -112.13% |
| Profit Margin | -112.57% |
| EBITDA Margin | -86.1% |
| EBIT Margin | -99.72% |
| FCF Margin | -103.1% |
Dividends & Yields
OM does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | -19.66% |
| FCF Yield | -52.94% |
Analyst Forecast
The average price target for OM is $45, which is 259.7% higher than the current price. The consensus rating is "Buy".
| Price Target | $45 |
| Price Target Difference | 259.7% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
Stock Splits
The last stock split was on Mar 20, 2025. It was a backward split with a ratio of 1:15.
| Last Split Date | Mar 20, 2025 |
| Split Type | backward |
| Split Ratio | 1:15 |
Scores
| Altman Z-Score | -4.98 |
| Piotroski F-Score | 4 |